In recent times, significant cuts to foreign aid, particularly from the United States Agency for International Development (USAID), have begun to unravel essential programs that are pivotal in managing and preventing disease outbreaks globally. As these funds shrink, dangerous pathogens, previously kept under stringent control, now find an environment free of the safeguards that once secured them. Reports indicate that unsecured pathogens are lingering in laboratories across Africa while inspection programs for infections like mpox and Ebola have been halted—a situation compounded by the cross-border movement of millions of unscreened animals.

Scientists and health officials emphasize that the ramifications of these cuts not only impact vulnerable populations in developing countries but also have the potential to compromise health security in the U.S. Dr. Githinji Gitahi, the head of Amref Health Africa, points out that outbreaks originating overseas can swiftly affect American populations, as evidenced during past epidemics. He stresses that the continued battle against diseases is a matter of American public interest, stating, “It’s actually in the interest of American people to keep diseases down.”

Current and former officials from various health organizations have shared concerns regarding a global health landscape that has deteriorated rapidly, due to diminished support for programs aimed at outbreak prevention and management. As funding decreases, the risk of widespread disease spread increases, creating a precarious situation that necessitates immediate attention and action to safeguard not just foreign communities, but citizens back at home as well.